ATE538801T1 - Therapeutische zusammensetzungen mit mindestens einem pyrrolobenzodiazepin-derivat und fludarabin - Google Patents
Therapeutische zusammensetzungen mit mindestens einem pyrrolobenzodiazepin-derivat und fludarabinInfo
- Publication number
- ATE538801T1 ATE538801T1 AT05762344T AT05762344T ATE538801T1 AT E538801 T1 ATE538801 T1 AT E538801T1 AT 05762344 T AT05762344 T AT 05762344T AT 05762344 T AT05762344 T AT 05762344T AT E538801 T1 ATE538801 T1 AT E538801T1
- Authority
- AT
- Austria
- Prior art keywords
- fludarabine
- compositions containing
- therapeutic compositions
- pyrrolobenzodiazepine derivative
- pyrrolobenzodiazepine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0404424A FR2869231B1 (fr) | 2004-04-27 | 2004-04-27 | Composition therapeutique contenant au moins un derive de la pyrrolobenzodiazepine et la fludarabine |
PCT/FR2005/001025 WO2005105113A2 (fr) | 2004-04-27 | 2005-04-26 | Composition therapeutique contenant au moins un derive de la pyrrolobenzodiazepine et la fludarabine |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE538801T1 true ATE538801T1 (de) | 2012-01-15 |
Family
ID=34947843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05762344T ATE538801T1 (de) | 2004-04-27 | 2005-04-26 | Therapeutische zusammensetzungen mit mindestens einem pyrrolobenzodiazepin-derivat und fludarabin |
Country Status (14)
Country | Link |
---|---|
US (1) | US8034808B2 (de) |
EP (1) | EP1742644B1 (de) |
JP (1) | JP5046922B2 (de) |
AT (1) | ATE538801T1 (de) |
CA (1) | CA2564603C (de) |
CY (1) | CY1112387T1 (de) |
DK (1) | DK1742644T3 (de) |
ES (1) | ES2377066T3 (de) |
FR (1) | FR2869231B1 (de) |
NO (1) | NO338380B1 (de) |
PL (1) | PL1742644T3 (de) |
PT (1) | PT1742644E (de) |
SI (1) | SI1742644T1 (de) |
WO (1) | WO2005105113A2 (de) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2869231B1 (fr) | 2004-04-27 | 2008-03-14 | Sod Conseils Rech Applic | Composition therapeutique contenant au moins un derive de la pyrrolobenzodiazepine et la fludarabine |
GB0410725D0 (en) * | 2004-05-13 | 2004-06-16 | Spirogen Ltd | Pyrrolobenzodiazepine therapeutic agents |
DE102008050988A1 (de) * | 2008-09-01 | 2010-03-04 | Gerd Reime | Identifikationselement mit einem optischen Transponder |
GB0819095D0 (en) | 2008-10-17 | 2008-11-26 | Spirogen Ltd | Pyrrolobenzodiazepines |
US8697688B2 (en) | 2010-04-15 | 2014-04-15 | Seattle Genetics Inc. | Pyrrolobenzodiazepines used to treat proliferative diseases |
WO2011130613A1 (en) | 2010-04-15 | 2011-10-20 | Seattle Genetics, Inc. | Targeted pyrrolobenzodiazapine conjugates |
US20130058947A1 (en) | 2011-09-02 | 2013-03-07 | Stem Centrx, Inc | Novel Modulators and Methods of Use |
AU2012311505B2 (en) | 2011-09-20 | 2016-09-29 | Medimmune Limited | Pyrrolobenzodiazepines as unsymmetrical dimeric PBD compounds for inclusion in targeted conjugates |
AU2012322613B2 (en) | 2011-10-14 | 2016-04-21 | Medimmune Limited | Pyrrolobenzodiazepines and targeted conjugates |
CN108164551A (zh) | 2011-10-14 | 2018-06-15 | 西雅图基因公司 | 吡咯并苯并二氮杂卓和靶向结合物 |
US9388187B2 (en) | 2011-10-14 | 2016-07-12 | Medimmune Limited | Pyrrolobenzodiazepines |
AU2012322934B2 (en) | 2011-10-14 | 2016-09-08 | Medimmune Limited | Pyrrolobenzodiazepines |
EP3539985A1 (de) | 2012-02-24 | 2019-09-18 | AbbVie Stemcentrx LLC | Anti-sez6-antikörper und verfahren zur verwendung |
PE20190658A1 (es) | 2012-02-24 | 2019-05-08 | Abbvie Stemcentrx Llc | Moduladores y metodos de empleo novedosos |
AU2013328623B8 (en) | 2012-10-12 | 2017-06-15 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-antibody conjugates |
CA2885305C (en) | 2012-10-12 | 2019-11-12 | Spirogen Sarl | Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation |
SI2906253T1 (sl) | 2012-10-12 | 2018-11-30 | Adc Therapeutics Sa | Konjugati pirolobenzodiazepin-protitelo proti PSMA |
NZ707543A (en) | 2012-10-12 | 2018-09-28 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-antibody conjugates |
ES2680153T3 (es) | 2012-10-12 | 2018-09-04 | Adc Therapeutics Sa | Conjugados de anticuerpos anti-PSMA-pirrolobenzodiazepinas |
CN110256469B (zh) | 2012-10-12 | 2022-05-17 | 麦迪穆有限责任公司 | 吡咯并苯并二氮杂卓及其结合物 |
ES2530968T3 (es) | 2012-10-12 | 2015-03-09 | Spirogen Sarl | Pirrolobenzodiazepinas y conjugados de las mismas |
ES2649990T3 (es) | 2012-10-12 | 2018-01-16 | Medimmune Limited | Conjugados de anticuerpos anti-CD22-pirrolobenzodiazepinas |
US10695433B2 (en) | 2012-10-12 | 2020-06-30 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
US10131682B2 (en) | 2012-11-24 | 2018-11-20 | Hangzhou Dac Biotech Co., Ltd. | Hydrophilic linkers and their uses for conjugation of drugs to a cell binding molecules |
CA2894961C (en) | 2012-12-21 | 2020-09-15 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
US9567340B2 (en) | 2012-12-21 | 2017-02-14 | Medimmune Limited | Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases |
HUE043851T2 (hu) | 2013-02-22 | 2019-09-30 | Abbvie Stemcentrx Llc | Anti-DLL3-antitest-PBD konjugátumok és alkalmazásuk |
CA2901941C (en) | 2013-03-13 | 2020-04-07 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
AU2014229529B2 (en) | 2013-03-13 | 2018-02-15 | Medimmune Limited | Pyrrolobenzodiazepines and conjugates thereof |
ES2523901B1 (es) * | 2013-05-31 | 2015-12-02 | Universidad Autónoma de Madrid | Uso de la deguelina como terapia suplementaria de la leucemia linfoide crónica |
SG11201601424PA (en) | 2013-08-28 | 2016-03-30 | Stemcentrx Inc | Site-specific antibody conjugation methods and compositions |
EP3038634A4 (de) | 2013-08-28 | 2017-10-11 | AbbVie Stemcentrx LLC | Neuartige sez6-modulatoren und verfahren zur verwendung |
GB201317982D0 (en) | 2013-10-11 | 2013-11-27 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
GB201317981D0 (en) | 2013-10-11 | 2013-11-27 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
WO2015052535A1 (en) | 2013-10-11 | 2015-04-16 | Spirogen Sàrl | Pyrrolobenzodiazepine-antibody conjugates |
WO2015052532A1 (en) | 2013-10-11 | 2015-04-16 | Spirogen Sàrl | Pyrrolobenzodiazepine-antibody conjugates |
WO2015052534A1 (en) | 2013-10-11 | 2015-04-16 | Spirogen Sàrl | Pyrrolobenzodiazepine-antibody conjugates |
US10053511B2 (en) | 2013-11-06 | 2018-08-21 | Abbvie Stemcentrx Llc | Anti-claudin antibodies and methods of use |
AU2014361856A1 (en) | 2013-12-12 | 2016-06-30 | Abbvie Stemcentrx Llc | Novel anti-DPEP3 antibodies and methods of use |
JP2017514143A (ja) | 2014-02-21 | 2017-06-01 | アッヴィ・ステムセントルクス・エル・エル・シー | メラノーマに使用するための抗dll3抗体および薬物コンジュゲート |
CN114262344A (zh) | 2014-02-28 | 2022-04-01 | 杭州多禧生物科技有限公司 | 带电荷链接体及其在共轭反应上的应用 |
TW201617368A (zh) | 2014-09-05 | 2016-05-16 | 史坦森特瑞斯公司 | 新穎抗mfi2抗體及使用方法 |
DK3191135T3 (da) | 2014-09-12 | 2020-10-12 | Genentech Inc | Anti-HER2-antistoffer og immunokonjugater |
GB201416112D0 (en) | 2014-09-12 | 2014-10-29 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
CA2968447A1 (en) | 2014-11-25 | 2016-06-02 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-antibody conjugates and their use to treat neoplasms |
GB201506411D0 (en) | 2015-04-15 | 2015-05-27 | Bergenbio As | Humanized anti-axl antibodies |
GB201506402D0 (en) | 2015-04-15 | 2015-05-27 | Berkel Patricius H C Van And Howard Philip W | Site-specific antibody-drug conjugates |
CA2991973C (en) | 2015-07-12 | 2021-12-07 | Suzhou M-Conj Biotech Co., Ltd. | Bridge linkers for conjugation of a cell-binding molecule |
US9839687B2 (en) | 2015-07-15 | 2017-12-12 | Suzhou M-Conj Biotech Co., Ltd. | Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule |
MA43345A (fr) | 2015-10-02 | 2018-08-08 | Hoffmann La Roche | Conjugués anticorps-médicaments de pyrrolobenzodiazépine et méthodes d'utilisation |
GB201601431D0 (en) | 2016-01-26 | 2016-03-09 | Medimmune Ltd | Pyrrolobenzodiazepines |
GB201602356D0 (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
GB201602359D0 (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
CA3021098A1 (en) | 2016-04-21 | 2017-10-26 | Abbvie Stemcentrx Llc | Novel anti-bmpr1b antibodies and methods of use |
GB201607478D0 (en) | 2016-04-29 | 2016-06-15 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
GB201617466D0 (en) | 2016-10-14 | 2016-11-30 | Medimmune Ltd | Pyrrolobenzodiazepine conjugates |
KR20220150408A (ko) | 2016-11-14 | 2022-11-10 | 항저우 디에이씨 바이오테크 씨오, 엘티디 | 결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용 |
GB201702031D0 (en) | 2017-02-08 | 2017-03-22 | Medlmmune Ltd | Pyrrolobenzodiazepine-antibody conjugates |
AU2018217926B2 (en) | 2017-02-08 | 2019-10-03 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-antibody conjugates |
JP2020517609A (ja) | 2017-04-18 | 2020-06-18 | メディミューン リミテッド | ピロロベンゾジアゼピン複合体 |
EP3612234B1 (de) | 2017-04-20 | 2024-03-13 | ADC Therapeutics SA | Kombinationstherapie mit anti-axl-antikörper-arzneimittel-konjugat |
US11318211B2 (en) | 2017-06-14 | 2022-05-03 | Adc Therapeutics Sa | Dosage regimes for the administration of an anti-CD19 ADC |
SI3668874T1 (sl) | 2017-08-18 | 2022-04-29 | Medimmune Limited | Pirolobenzodiazepinski konjugati |
GB201803342D0 (en) | 2018-03-01 | 2018-04-18 | Medimmune Ltd | Methods |
GB201806022D0 (en) | 2018-04-12 | 2018-05-30 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4188378A (en) * | 1978-01-04 | 1980-02-12 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Anticancer and antiviral activity of 9-β-D-arabinofuranosyl-2-fluoroadenine |
GB9818731D0 (en) * | 1998-08-27 | 1998-10-21 | Univ Portsmouth | Compounds |
ATE294803T1 (de) * | 1998-08-27 | 2005-05-15 | Spirogen Ltd | Pyrrolobenzodiazepine |
CA2419060A1 (en) * | 2000-08-09 | 2002-02-14 | The Regents Of The University Of California | Indole compounds useful for the treatment of cancer |
EP1480676A1 (de) * | 2002-02-28 | 2004-12-01 | Novartis AG | Kombination eines atp-kompetitiven inhibitors der c-abl kinase mit zwei oder mehreren antineoplastischen mitteln |
EP1675857B1 (de) | 2003-10-22 | 2011-07-13 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Pyrrolobenzodiazepinderivate, zusammensetzungen, die diese enthalten, und damit in zusammenhang stehende verfahren |
FR2869231B1 (fr) | 2004-04-27 | 2008-03-14 | Sod Conseils Rech Applic | Composition therapeutique contenant au moins un derive de la pyrrolobenzodiazepine et la fludarabine |
-
2004
- 2004-04-27 FR FR0404424A patent/FR2869231B1/fr not_active Expired - Fee Related
-
2005
- 2005-04-26 AT AT05762344T patent/ATE538801T1/de active
- 2005-04-26 PT PT05762344T patent/PT1742644E/pt unknown
- 2005-04-26 US US11/587,962 patent/US8034808B2/en not_active Expired - Fee Related
- 2005-04-26 PL PL05762344T patent/PL1742644T3/pl unknown
- 2005-04-26 EP EP05762344A patent/EP1742644B1/de active Active
- 2005-04-26 WO PCT/FR2005/001025 patent/WO2005105113A2/fr active Application Filing
- 2005-04-26 JP JP2007510074A patent/JP5046922B2/ja not_active Expired - Fee Related
- 2005-04-26 SI SI200531475T patent/SI1742644T1/sl unknown
- 2005-04-26 CA CA2564603A patent/CA2564603C/fr not_active Expired - Fee Related
- 2005-04-26 DK DK05762344.9T patent/DK1742644T3/da active
- 2005-04-26 ES ES05762344T patent/ES2377066T3/es active Active
-
2006
- 2006-11-21 NO NO20065368A patent/NO338380B1/no not_active IP Right Cessation
-
2012
- 2012-02-22 CY CY20121100181T patent/CY1112387T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP1742644B1 (de) | 2011-12-28 |
NO20065368L (no) | 2006-11-21 |
NO338380B1 (no) | 2016-08-15 |
PL1742644T3 (pl) | 2012-05-31 |
CY1112387T1 (el) | 2015-12-09 |
CA2564603A1 (en) | 2005-11-10 |
DK1742644T3 (da) | 2012-04-16 |
WO2005105113A2 (fr) | 2005-11-10 |
PT1742644E (pt) | 2012-03-02 |
EP1742644A2 (de) | 2007-01-17 |
US20070232592A1 (en) | 2007-10-04 |
ES2377066T3 (es) | 2012-03-22 |
FR2869231B1 (fr) | 2008-03-14 |
FR2869231A1 (fr) | 2005-10-28 |
JP5046922B2 (ja) | 2012-10-10 |
US8034808B2 (en) | 2011-10-11 |
WO2005105113A3 (fr) | 2007-02-22 |
CA2564603C (fr) | 2014-07-29 |
JP2007534730A (ja) | 2007-11-29 |
SI1742644T1 (sl) | 2012-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE538801T1 (de) | Therapeutische zusammensetzungen mit mindestens einem pyrrolobenzodiazepin-derivat und fludarabin | |
LUC00011I2 (de) | ||
AR028296A1 (es) | Metodos sinergisticos y composiciones para el tratamiento del cancer | |
TW200716091A (en) | New therapeutic combinations for the treatment or prevention of psychotic disorders |